Positive glypican-3 expression in early hepatocellular carcinoma predicts recurrence after hepatectomy 
<<view abstract in PubMed >>

Copyright 2013  -   BioMosaics Inc. 655 Spear St. Building C, Burlington, VT 05405  -  +1 877 742-2066

 

Welcome to BioMosaics

BioMosaics is a biomarker development company.  We commercialize assays and reagents for the early detection of cancer, for use in clinical and research settings.  In addition to our antibody products for clinical immunohistochemistry, we are developing novel oncology immunoassays for tumor markers, as well as assays for detection of DNA damage and somatic mutation.

MCJ/DnaJC15, an endogenous mitochondrial repressor of the respiratory chain that controls metabolic alterations.   <<view abstract in PubMed >>

Methylation-controlled J-protein MCJ acts in the import of proteins into human mitochondria  
<<view abstract in PubMed >>